Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5

被引:10
|
作者
Zombori, Tamas [1 ]
Cserni, Gabor [1 ,2 ]
机构
[1] Univ Szeged, Dept Pathol, Fac Med, Allomas U 1, H-6725 Szeged, Hungary
[2] Bacs Kiskun Cty Teaching Hosp, Dept Pathol, Kecskemet, Hungary
关键词
Basal-like; Triple negative breast cancer; GATA-3; Mammaglobin; GCDFP-15; NY-BR-1; DISEASE FLUID PROTEIN-15; DIFFERENTIATION ANTIGEN NY-BR-1; UTEROGLOBIN GENE FAMILY; FEMALE GENITAL-TRACT; GATA3; IMMUNOHISTOCHEMISTRY; ESTROGEN-RECEPTOR; CLINICOPATHOLOGICAL ANALYSIS; MAMMAGLOBIN EXPRESSION; DIAGNOSTIC UTILITY; IDENTIFICATION;
D O I
10.1007/s12253-017-0246-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Estrogen and progesterone receptors are possible markers for suggesting a mammary origin of metastatic carcinoma, but are useless in cases of triple negative breast cancers (TNBC). Five other potential markers of breast origin were investigated on tissue microarrays in a series of TNBCs showing keratin 5 expression, consistent with a basal-like phenotype. GATA-3 staining was observed in 82 of 115 triple negative cases (71.3%) including 23 cases with > 5% staining. Mammaglobin staining was detected in 30 cases (26.0%) including 12 with > 5% staining. GCDFP-15 was seen in 23 cases (20.0%) including 9 with > 5% staining. NY-BR-1 positivity was present in 7 cases (6.0%) including 3 patients with > 5% staining. BCA-225 staining was observed in 74 cases (64.3%); however this latter marker lacks also specificity owing to the reported widespread staining in other malignancies. GATA-3, mammaglobin and GCDFP-15 coexpression was seen in one case (0.9%), whereas GATA-3 and mammaglobin or mammaglobin and GCDFP-15 coexpression was present in 2 and 2 cases (1.7%), respectively. Using at least 5% staining as cut-off, the expression of any of the last 4 markers was 34.7%. The expression of GATA-3, mammaglobin, GCDFP-15 and NY-BR-1 is lower in TNBC-s than in breast carcinomas in general, and this may be even lower in basal-like carcinomas. Although these markers are not fully specific, by using them, a subset of basal-like TNBC-s can be identified as of mammary origin. However, a substantial proportion will not show any staining with any of these markers.
引用
收藏
页码:259 / 267
页数:9
相关论文
共 50 条
  • [31] Triple negative, "basal-like" breast cancer: an institutional review
    Herms, B. T.
    Jain, D.
    Chagpar, A. B.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S278 - S279
  • [32] Targeting Basal-Like Breast Cancers
    Dey, Nandini
    Smith, Brian R.
    Leyland-Jones, B.
    CURRENT DRUG TARGETS, 2012, 13 (12) : 1510 - 1524
  • [33] Are triple-negative and basal-like breast cancer synonymous?
    Rakha, Emad
    Ellis, Ian
    Reis-Filho, Jorge
    CLINICAL CANCER RESEARCH, 2008, 14 (02) : 618 - 618
  • [34] The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma
    Naoto Kuroda
    Masahiko Ohara
    Kaori Inoue
    Keiko Mizuno
    Nokiaki Fujishima
    Nobumasa Hamaguchi
    Gang-Hong Lee
    Medical Molecular Morphology, 2009, 42 : 128 - 131
  • [35] Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)
    Lerma, Enrique
    Peiro, Gloria
    Ramon, Teresa
    Fernandez, Sonia
    Martinez, Daniel
    Pons, Cristina
    Munoz, Fina
    Sabate, Josep Ma
    Alonso, Carmen
    Ojeda, Belen
    Prat, Jaime
    Barnadas, Agusti
    MODERN PATHOLOGY, 2007, 20 (11) : 1200 - 1207
  • [36] Basal-Like and Triple-Negative Breast Cancers Searching for Positives Among Many Negatives
    Alluri, Prasanna
    Newman, Lisa A.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 23 (03) : 567 - +
  • [37] The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma
    Kuroda, Naoto
    Ohara, Masahiko
    Inoue, Kaori
    Mizuno, Keiko
    Fujishima, Nokiaki
    Hamaguchi, Nobumasa
    Lee, Gang-Hong
    MEDICAL MOLECULAR MORPHOLOGY, 2009, 42 (02) : 128 - 131
  • [38] TNBL: An Integrated Knowledge Space of Triple-Negative and Basal-Like Breast Cancers.
    Zhu, J.
    CANCER RESEARCH, 2011, 71
  • [39] Triple Negative Breast Cancers and Basal Immunophenotypic Expression
    Tan, P. H.
    Thike, A. A.
    Cheok, P. Y.
    MODERN PATHOLOGY, 2009, 22 : 71A - 71A
  • [40] Triple Negative Breast Cancers and Basal Immunophenotypic Expression
    Tan, P. H.
    Thike, A. A.
    Cheok, P. Y.
    LABORATORY INVESTIGATION, 2009, 89 : 71A - 71A